BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17364467)

  • 21. Preparation and characterization of crosslinked and polymerized hemoglobin solutions.
    Bakker JC; Berbers GA; Bleeker WK; den Boer PJ; Biessels PT
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):233-41. PubMed ID: 1391437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation, characterization and in vivo investigation of blood-compatible hemoglobin-loaded nanoparticles as oxygen carriers.
    Lu M; Zhao C; Wang Q; You G; Wang Y; Deng H; Chen G; Xia S; Zhao J; Wang B; Li X; Shao L; Wu Y; Zhao L; Zhou H
    Colloids Surf B Biointerfaces; 2016 Mar; 139():171-9. PubMed ID: 26708138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The proton Bohr factor of native and crosslinker treated hemoglobins--its possible significance for the efficacy of hemoglobin based artificial oxygen carriers.
    Barnikol WK
    Adv Exp Med Biol; 1994; 361():363-70. PubMed ID: 7597959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design of recombinant hemoglobins for use in transfusion fluids.
    Fronticelli C; Koehler RC
    Crit Care Clin; 2009 Apr; 25(2):357-71, Table of Contents. PubMed ID: 19341913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-volume resuscitation cocktail extends survival after severe hemorrhagic shock.
    Reynolds PS; Barbee RW; Skaflen MD; Ward KR
    Shock; 2007 Jul; 28(1):45-52. PubMed ID: 17483745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Filtration of diaspirin crosslinked hemoglobin into lung and soft tissue lymph.
    Conhaim RL; Cooler SD; McGrath AM; DeAngeles DA; Myers GA; Harms BA
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1204-12. PubMed ID: 9769283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the kidneys in the excretion of chemically modified hemoglobins.
    Keipert PE; Gomez CL; Gonzales A; Macdonald VW; Winslow RM
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):737-45. PubMed ID: 1391505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down selection of polymerized bovine hemoglobins for use as oxygen releasing therapeutics in a guinea pig model.
    Baek JH; Zhou Y; Harris DR; Schaer DJ; Palmer AF; Buehler PW
    Toxicol Sci; 2012 Jun; 127(2):567-81. PubMed ID: 22416071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional cross-linked hemoglobin bis-tetramers: geometry and cooperativity.
    Hu D; Kluger R
    Biochemistry; 2008 Nov; 47(47):12551-61. PubMed ID: 18956893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety Evaluation of Hemoglobin-Albumin Cluster "HemoAct" as a Red Blood Cell Substitute.
    Haruki R; Kimura T; Iwasaki H; Yamada K; Kamiyama I; Kohno M; Taguchi K; Nagao S; Maruyama T; Otagiri M; Komatsu T
    Sci Rep; 2015 Jul; 5():12778. PubMed ID: 26220366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
    Taguchi K; Maruyama T; Otagiri M
    Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified haemoglobins as oxygen-transporting blood substitutes.
    Mallick A; Bodenham AR
    Br J Hosp Med; 1996 Apr 3-16; 55(7):443-8. PubMed ID: 8730571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cross-linking and zero-link polymerization on oxygen transport and redox chemistry of bovine hemoglobin.
    Jia Y; Alayash AI
    Biochim Biophys Acta; 2009 Aug; 1794(8):1234-42. PubMed ID: 19409516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemoglobin-based oxygen carriers and trials to substitute red blood cells].
    Smani Y; Labrude P; Vigneron C; Faivre B
    Transfus Clin Biol; 2007 Nov; 14(5):464-73. PubMed ID: 18295525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemoglobinuria in rats: a sensitive test of renal filtering and absorption of PEG-hemoglobin, a red blood cell substitute.
    Gilbert C; Nho K; Johnson M; Linberg R; Shorr R
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):535-41. PubMed ID: 7994375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red cell substitutes from hemoglobin--do we start all over again?
    Kluger R
    Curr Opin Chem Biol; 2010 Aug; 14(4):538-43. PubMed ID: 20392662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilities and properties of multilinked hemoglobins.
    Olsen KW; Zhang QY; Huang H; Sabaliauskas GK; Yang T
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):283-5. PubMed ID: 1391443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tris(3,5-dibromosalicyl) tricarballylate crosslinked hemoglobin: functional evaluation.
    Zheng Y; Olsen KW
    Artif Cells Blood Substit Immobil Biotechnol; 1996 Nov; 24(6):587-98. PubMed ID: 8922228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Cl- and H+ on the oxygen binding properties of glutaraldehyde-polymerized bovine hemoglobin-based blood substitutes.
    Eike JH; Palmer AF
    Biotechnol Prog; 2004; 20(5):1543-9. PubMed ID: 15458341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization.
    Yu WP; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1996 May; 24(3):169-83. PubMed ID: 8773737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.